Cutting Edge : Fc gamma RIII (CD16) and Fc gamma RI (CD64) are responsible for anti-glycoprotein 75 monoclonal antibody TA99 therapy for experimental metastatic B16 melanoma (vol 189, pg 5513, 2012)